Cyteir Therapeutics, Inc.
CYT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $147 | $190 | $11 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | -$0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $1 | $1 |
| Total Curr. Assets | $149 | $193 | $12 | $30 |
| Property Plant & Equip (Net) | $2 | $2 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $0 | $0 | $0 |
| Total NC Assets | $4 | $2 | $2 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $153 | $195 | $14 | $31 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $1 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $6 | $1 | $1 |
| Total Curr. Liab. | $5 | $8 | $3 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $1 | $59 | $58 |
| Total NC Liab. | $2 | $1 | $59 | $58 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $7 | $8 | $62 | $60 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $195 | $57 | $57 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$138 | -$92 | -$50 | -$29 |
| AOCI | $0 | -$195 | -$57 | -$57 |
| Other Equity | $284 | $279 | $2 | $1 |
| Total Equity | $146 | $187 | -$48 | -$28 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $153 | $195 | $14 | $31 |
| Net Debt | -$146 | -$190 | -$11 | -$29 |